Lipton RB, et al. Patient Global Impression of Change related to improvement in most bothersome symptom following treatment with eptinezumab. IHC-PO-167. IHC 2019, 5-8 sept. Dublin, Ierland.
MS: COVID-19, uitgesteld doseren natalizumab en nieuwe middelen
dec 2020 | Multipele Sclerose